ALLOGENE THERAPEUTICS INC's ticker is and the CUSIP is 019770906. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15 | -11.8% | 5,000 | +42.9% | 0.00% | – |
| Q2 2023 | $17 | -78.5% | 3,500 | -78.3% | 0.00% | – |
| Q1 2023 | $79 | -68.4% | 16,100 | -59.5% | 0.00% | – |
| Q4 2022 | $250 | -99.8% | 39,800 | +167.1% | 0.00% | – |
| Q3 2022 | $160,000 | -20.4% | 14,900 | -15.8% | 0.00% | – |
| Q2 2022 | $201,000 | +139.3% | 17,700 | +90.3% | 0.00% | – |
| Q1 2022 | $84,000 | -20.0% | 9,300 | +31.0% | 0.00% | – |
| Q4 2021 | $105,000 | +150.0% | 7,100 | +343.8% | 0.00% | – |
| Q3 2021 | $42,000 | +2.4% | 1,600 | 0.0% | 0.00% | – |
| Q2 2021 | $41,000 | -92.6% | 1,600 | +912.7% | 0.00% | -100.0% |
| Q1 2021 | $557,000 | +34.9% | 158 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $413,000 | +1151.5% | 164 | +1722.2% | 0.00% | – |
| Q3 2020 | $33,000 | -87.5% | 9 | -85.5% | 0.00% | – |
| Q2 2020 | $265,000 | +960.0% | 62 | +376.9% | 0.00% | – |
| Q1 2020 | $25,000 | -96.7% | 13 | -95.6% | 0.00% | -100.0% |
| Q4 2019 | $763,000 | +295.3% | 294 | +314.1% | 0.00% | +100.0% |
| Q3 2019 | $193,000 | +89.2% | 71 | +86.8% | 0.00% | – |
| Q2 2019 | $102,000 | -11.3% | 38 | -5.0% | 0.00% | – |
| Q1 2019 | $115,000 | +1050.0% | 40 | +900.0% | 0.00% | – |
| Q4 2018 | $10,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $10,374 | 0.00% |
| SIMPLEX TRADING, LLC | 16,100 | $79 | 0.00% |